NCT00482664 - The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women With Female Sexual Arousal Disorder. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

October 31, 2008

Conditions

Sexual Dysfunction, Physiological

Interventions

DRUG

CP-866,087

Tablets for oral administration

DRUG

CP-866,087

Tablets for oral administration

DRUG

CP-866,087

Tablets for oral administration

DRUG

Placebo

Tablets for oral administration

Trial Locations (12)

2100

Pfizer Investigational Site, Kobenhavn OE

3629

Pfizer Investigational Site, Westville

5000

Pfizer Investigational Site, Odense C

5065

Pfizer Investigational Site, Dulwich

6009

Pfizer Investigational Site, Nedlands

8000

Pfizer Investigational Site, Aarhus C

0277

Pfizer Investigational Site, Oslo

0132

Pfizer Investigational Site, Pretoria

221 85

Pfizer Investigational Site, Lund

541 30

Pfizer Investigational Site, Skövde

141 86

Pfizer Investigational Site, Stockholm

S-182 88

Pfizer Investigational Site, Stockholm